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Abstract: Ovarian cancer has the lowest survival rate of the gynecologic 
cancers because it is predominantly diagnosed in the late stages due to the 
lack of reliable symptoms and efficacious screening techniques. A novel 
hybrid  intraoperative  probe  has  been  developed  and  evaluated  for  its 
potential  role  in  detecting  and  characterizing  ovarian  tissue.  The  hybrid 
intraoperative dual-modality device consists of multiple scintillating fibers 
and  an  optical  coherence  tomography  imaging  probe  for  simultaneously 
mapping  the  local  activities  of 
18F-FDG  uptake  and  imaging  of  local 
morphological  changes  of  the  ovary.  Ten  patients  were  recruited  to  the 
study  and  a  total  of  18  normal,  abnormal  and  malignant  ovaries  were 
evaluated  ex  vivo  using  this  device.  Positron  count  rates  of  7.5/8.8-fold 
higher were found between malignant and abnormal/normal ovaries. OCT 
imaging  of  malignant  and  abnormal  ovaries  revealed  many  detailed 
morphologic features that could be potentially valuable for evaluating local 
regions with high metabolic activities and detecting early malignant changes 
in the ovary. These initial results have demonstrated that our novel hybrid 
imager has great potential for ovarian cancer detection and characterization 
during minimally invasive endoscopic procedures. 
© 2011 Optical Society of America 
OCIS codes: (170.4500) Optical Coherence Tomography; (170.3880) Medical and biological 
imaging; (170.3890) Medical optics instrumentation; (170.4440) ObGyn. 
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1. Introduction 
Ovarian  cancer  has  the  lowest  survival  rate  of  the  gynecologic  cancers  because  it  is 
predominantly diagnosed in Stages III and IV due to the lack of reliable symptoms as well as 
the  lack  of  efficacious  screening  techniques.  High  risk  women,  who  warrant  screening 
because of their increased prevalence of the disease, do not have an effective screening tool to 
detect early cancers. In 2002, two landmark studies [1,2] were published on the benefit of 
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women carrying a BRCA 1 or 2 mutations. PO reduces the risk of ovarian cancer by more 
than 80%. In the absence of reliable methods of early detection of ovarian cancer, PO has 
been proposed as the most effective way to prevent this potentially lethal disease in this group 
of  women. Although PO is effective in preventing breast and ovarian cancer, it has been 
recently found to increase mortality of women undergoing oophorectomy prior to the age of 
45 [3] or even before the age of 55-60 [4]. These high risk women are not candidates for 
hormone replacement therapy because of their increased risk of breast cancer [3]. Thus, there 
is an urgent need to minimize the use of PO which is the major rationale for developing better 
and more sensitive tools to effectively evaluate the ovary during minimally invasive surgery. 
Positron emission tomography (PET), using 
18F-fluoro-2-deoxy-d-glucose (
18F-FDG) as a 
tracer, can detect malignant cancers with altered glucose metabolism. However, it has limited 
value  in  lesion  localization  in  early  stages  of  ovarian  cancer  because  of  the  difficulty  in 
distinguishing between the signal from early-stage cancers and the background uptake signals 
coming from the normal tissue [5]. The average tissue path length of 511 keV gamma ray 
produced by 
18F-FDG is about 10 centimeters. As a result, the gamma signal from a small 
tumor is contaminated by the signal from the surrounding healthy tissue. Intraoperative probes 
which are selectively sensitive to short-range beta radiation have the significant advantage of 
detecting  early-stage  cancers  [6,7].  The  average  tissue  path  length  for 
18F  beta  particles 
(β633.5keV) is a few millimeters [8] and it corresponds well with targeted internal organs, 
such  as  ovary,  colon,  and  cardiac  vessels  before  these  particles  interact  with  electrons  to 
produce  annihilating  511  keV  gamma  photons.  A  number  of  investigators  are  developing 
intraoperative or intravascular radiation detection systems for the early detection of cancers or 
atherosclerosis [6–10]. Many of the detectors proposed for use in beta-sensitive probes have 
utilized  plastic  scintillators  [7–9,11],  which  convert  ionizing  particles  into  photons.  In 
addition to scintillation detectors, solid-state devices have also been proposed for use in beta 
probes  [12].  Furthermore,  several  groups  have  designed  and  built  imaging  beta  cameras 
[13,14].  While  these  groups  are  developing  radiation  detectors  for  intraoperative  or 
intravascular use, we have linked this type of functional intraoperative radiation detection 
with Optical Coherence Tomography (OCT) device that allows simultaneous high-resolution 
imaging of tissue morphology. OCT is an emerging high resolution imaging technique which 
measures backscattered light generated from an infrared light source directed at the tissues 
being examined [15]. OCT typically obtains a resolution capability of 5 15 µm and a depth 
of penetration of 1-2 mm and has been used to image tissues in the body that can be accessed 
either directly or via endoscope or catheter, including the eye [16–18], coronary blood vessels 
[19,20], GI track [21,22], colon [23] and ovary [24–27]. OCT is sensitive to collagen changes 
which were seen as malignancy develops [27]. 
In our previous publication [28,29], we introduced a novel hybrid intraoperative imaging 
device, which integrates multiple scintillating fibers and an OCT imaging probe for mapping 
the local uptake of 
18F-FDG and imaging morphological details of the rabbit atherosclerotic 
model and ovary. This hybrid imager has potential applications in ovarian cancer screening 
and diagnosis during minimally invasive endoscope procedures. In this paper, we report the 
first ex vivo studies of 18 normal, abnormal and malignant ovaries obtained from 10 human 
patients using this device. 
2. Methods 
2.1. Hybrid probe 
The hybrid probe, which is shown within the blue dashed rectangle in Figs. 1(a-b), consists of 
a side-view ball lens OCT fiber and ten plastic scintillating fibers. The side and tissue surface 
views of the hybrid probe are shown in Figs. 1 (c-d), and the photographs of the probe and the 
experimental setup are shown in Figs. 1(e-f). The central OCT fiber of diameter 0.5mm scans 
the 3-D volume of 2 mm (depth) × 5 mm (lateral) × 7 mm (longitudinal) underneath the 
probe. The ten scintillating fibers straddle the OCT channel in the arrangement of 2 × 4 for 
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scintillating fiber tips is 4.25 mm and the longitudinal spacing is 1.75 mm. Each scintillating 
fiber is a 3 mm long and 1 mm diameter plastic scintillating fiber (Saint-Gobain) epoxied to a 
plastic optical fiber of the same diameter and 1.2 meter long. The scintillating fiber tip is 
coated with reflective paint to enhance the light collection. The scintillating fibers are not only 
sensitive  to  positrons  but  also  to  gamma  rays  generated  from  positron  annihilation  in 
surrounding  tissue.  The  high  gamma  background  can  therefore  produce  high  background 
levels even  with a positron-to-gamma sensitivity ratio of 10-13:1 typical of low-Z plastic 
scintillators [9,29]. In order to reduce the impact of gamma contamination, two separate 0.25 
mm-thick Cu-shielded fibers measure the approximate gamma background levels that are then 
subtracted from the total detector counts. They are referred to as “beta-insensitive or gamma 
detectors”. The remaining eight  scintillating detectors are referred to as “beta-sensitive or 
positron detectors”. 
 
Fig. 1. (a) Schematic of swept-source OCT system. (b) Schematic of positron detection system. 
(c) Side view  of the hybrid probe integrating OCT fiber and nuclear detectors. (d) Tissue 
surface view of the hybrid probe; (e) Photograph of the hybrid probe. (f) Experimental setup; 
(g) Co-registration scheme of surface positron distribution map and a sequence of OCT images. 
2.2. OCT system 
Figure 1(a) depicts the schematic of Fourier Domain OCT system which is based on a 110 nm 
bandwidth swept source (HSL-2000, Santec Corp., Japan) with center wavelength of 1310 nm 
and scan rate of 20 kHz. The 10 mW output power from the swept source was evenly split 
into reference and sample arms by a 2 × 2 coupler. A fiber optic rotary joint (Princetel Inc.) 
was  inserted  in  the  sample  arm,  to  enable  continuous  circumferential  scanning.  The 
backscattered or back-reflected light was collected by a side view ball lens catheter (WT&T 
Inc.,  Canada)  and  recombined  with  the  reference  light  at  the  second  2  ×  2  coupler.  The 
interferogram formed was detected by a balanced detector (Thorlabs PDB120C) and acquired 
by a 50 MHz digitizer (Cs8325, Gage Applied) after a 20 MHz anti-alias filter. The system 
sensitivity was 109dB and the axial resolution was approximately 12 μm in air. The lateral 
resolution of 25 μm was achieved at working distance of 1 mm away from the side surface of 
the catheter. For the reduced rotation rate of 16 seconds per revolution used in the initial 
demonstration, the A-scan rate was decreased to 250 Hz using a divider circuit. Therefore, 
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displaying were done at the time when the motor completed the rotation from 180 to 360 
degrees. During image processing, a wavelength-dependent amplitude correction to the raw 
data was applied to account for the optical power variation during A-line scans. The scaled 
measurement data was interpolated to a uniform grid in k-space before Fourier transformation. 
2.3. Positron Detection System 
Figure 1 (b) depicts the configuration of the positron detection system composed of a position 
sensitive  PMT  (PSPMT,  Hamamatsu  R8900U),  front-end  electronics,  and  sampling-based 
multi-channel  analyzer  circuitry.  The  PSPMT  provides  6  X  and  6  Y  readout  anodes  for 
position  determination,  which  are  in  turn  amplified  and  connected  to  a  resistor  divider 
network  to  provide  four  outputs:  X1,  X2  and  Y1,  Y2.  Standard  Anger  logic  is  used  to 
calculate the event position and the total event energy [30]. The PSPMT that is used has 64 
light-sensitive  detection  areas,  with  each  area  measuring  2.5  mm  ×  2.5  mm.  The  ten 
scintillating input fibers separated by 2.5 mm were fed to the central region of the PSPMT, 
and the scattered photons that reached the areas outside of the central region were removed in 
the  data  processing.  The  positron  counts  from  eight  positron  detectors  were  obtained  by 
subtracting the average gamma background from the two beta-insensitive detectors. This was 
displayed as a positron distribution map or flood image and the summation was reported as 
the total counts. As each 2.5 × 2.5 mm
2 detection area on the PSPMT was larger than the 1 
mm diameter positron detector, the photons were proportionally distributed inside each circle 
of 1 mm diameter in the map. To determine the optimum counting time for the prototype 
probe and the system, the signal-to-background (SBR) ratio and the standard deviation (n = 5) 
vs. counting time using a 12.4 kBq 
204TI source was evaluated. The background counts were 
obtained in the absence of the TI source. Within a 1-minute period, the SBR reached a peak 
and stayed there afterwards, while the standard deviation reduced to 3% of the mean value 
after  3  minutes  and  remained  the  same  afterwards.  Therefore,  the  positron  counts  were 
recorded for 3 minutes for all patients in the reported study. 
The sensitivity of positron detectors was evaluated using 
18F-FDG radiotracer. This was 
done by filling a cylindrical glass well having a diameter of 25 mm with 0.5 ml 
18F-FDG of 
3.84 MBq/ml, and then suspending the probe 0.5 mm above the 
18F-FDG level. The measured 
probe sensitivity was 9086 cps/MBq. 
2.4. Patients 
The clinical study was performed at the University of Connecticut Health Center (UCHC) 
from  September  2009  to  September  2010.  The  study  protocol  was  approved  by  the 
Institutional Review Boards of UCHC and was HIPAA compliant. Signed informed consent 
was obtained from all patients. The eligible patients who were scheduled for oophorectomy 
were either at risk for ovarian cancer or they had an ovarian mass or pelvic mass suggesting 
malignancy. The study  group consisted of ten patients  whose ages ranged  from 32  to 79 
(mean  56).  Two  patients  were  premenopausal  women  and  the  rest  were  postmenopausal 
women. The 
18F-FDG was calibrated at the time of the injection with dose ranging from 484.7 
MBq to 643.8 MBq (mean 557.4 MBq). Approximately, 35-45 minutes after the injection, the 
patient was transported to the operating room and prepared for surgery. Immediately after 
disruption of the blood supply, the ovaries were removed and transported to an adjacent lab 
for positron detection and OCT imaging. The time difference between injection and the first 
measurement  for  the  ten  patients  varied  from  77  to  145  minutes  (mean  102  minutes). 
Typically, we started from the area pointed by the surgeon and then moved to other non-
overlapping locations parallel to the long axis of the probe. This way, the histological samples 
could  be  cut  consistently  for  correlating  H&E  stains  with  the  OCT  images.  The  positron 
distribution map corresponded to the probe plane and the sequence of OCT imaging planes 
was perpendicular to the probe plane as shown in Fig. 1(g). Depending on the size of the 
examined ovary, 3~9 non-overlapping areas were measured. All positron counts measured at 
different locations of the ovaries from the same patient were corrected to compensate for 
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all  the  positron  count  rates  of  the  different  patients  were  compared  at  injection  time  and 
normalized to the injection dose. After positron detection and imaging, the ovaries were fixed 
in  formalin  and  returned  to  the  Pathology  Department  for  histological  processing.  For 
histological evaluation, the ovaries were cut in 5 mm blocks parallel to the OCT imaging 
plane, dehydrated with graded alcohol, embedded in paraffin and sectioned to 7-μm thickness 
using  a  paraffin  microtome.  Once  the  slides  that  correspond  to  the  imaged  planes  were 
identified, they were stained using hematoxylin and eosin (H&E). In this study, two patients 
each had only one ovary available for this study. A total of eighteen ovaries from ten patients 
were investigated by our combined OCT and positron detection dual-modality system. 
3. Results 
3.1. Calibration 
A simple quick calibration was applied right before each patient study by using 160 kBq 
137Cs 
(β511.6  keV,  γ661.6  keV)  sealed  spherical  source  which  was  considered  as  a  stable 
radionuclide  with  half-life  30.1  years.  The  radioactive  source  was  placed  2mm  under  the 
center of the probe and monitored for 1 minute. The average total counts from eight positron 
detectors was 12035 (n = 10) and the standard deviation was 346 which was larger than the 
theoretically  predicted  value  of  110  based  on  Poisson  distribution.  However,  this  small 
difference  (2%  of  the  total  counts)  can  be  explained  by  the  slight  different  measurement 
conditions over this one year study period and the small sample size. The average of the total 
counts from two gamma detectors was 188 (n = 10) and the standard deviation was 30. We 
measured the beta-to-gamma sensitivity ratio of the scintillating fiber by placing a single fiber 
2 mm above the 160 kBq 
137Cs source. The total gamma counts were measured by inserting a 
0.25mm-thick  Cu  plate  between  the  scintillating  fiber  and  the  source  to  shield  the  beta 
particles. A ratio of 11.4 was obtained as (total counts (beta + gamma) – gamma counts) / 
(gamma counts), with both measurements being five minutes long. This ratio agrees with the 
data from literature and our previous measurements [9,29]. Based on this ratio, we expect to 
get  243  counts  for  2  beta-shielded  scintillators  as  compared  with  the  total  12035  counts 
obtained for the 8 beta sensitive scintillators. This small difference between predicted and 
measured can be explained by the slight different measurement conditions over this one year 
study period. Based on this calibration result, our nuclear detection sensitivity was about the 
same during this one-year patient study period. 
3.2. Patient results 
For the total of 10 patients studied, two patients had ovarian papillary serous carcinoma on 
both ovaries (#7 and #8), four patients had endometrial carcinoma (#3, #4, #6, #9), one patient 
had a benign dermoid tumor on one ovary (#10), one patient had enlarged ovaries of both 
sides (#1), and two patients had bilateral normal ovaries (#2, #5). To evaluate the metabolic 
activities of the ovaries from patients with endometrial cancer and compare their results with 
those obtained from patients with ovarian cancer, we have categorized this group of patients 
as the abnormal group. In addition, the right ovary of the patient who had a dermoid tumor 
was also categorized into the abnormal group. Thus the three groups are: normal (#1, #2, #5, 
#10  left  ovary),  abnormal  (#3,  #4,  #6,  #9,  #10  right  ovary)  and  malignant  (#7,  #8).  The 
patients’  information,  injection  dose,  time  delay  between  injection  and  measurement,  the 
average total positron counts per 3 minutes and the count rates (average total counts/injection 
activity) as well as the standard deviations for these three categories are given in Table 1. The 
average count rate and standard deviation from normal, abnormal and malignant groups were 
1.23 counts/MBq (0.38, n = 7), 1.44 counts/MBq (0.18, n = 8), and 10.78 (13.76, n = 3), 
respectively. On average, 1.2-fold higher total count rate was found between abnormal and 
normal groups, and 7.5- and 8.8-fold higher total count rates were found between malignant 
and abnormal, and malignant and normal groups, respectively. The range of count rates of the  
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Category  Patient#  Age 
Weight 
(kg) 
Injection 
Activity 
(MBq) 
TD
a 
(min) 
Counts 
(std
b, left) 
Count rate
 
(std
b, left) 
Counts 
(std
b, right) 
Count  
rate
 
(std
b, right) 
Normal 
#1  63  56  643.8  115  588(134)  0.91(0.21)  467(29)  0.72(0.04) 
#2  52  58  484.7  92  721(39)  1.49(0.08)  759(125)  1.57(0.26) 
#5  58  103  599.4  86  629(70)  1.05(0.12)  676(36)  1.13(0.06) 
#10 left  59  76  495.8  101  864(104)  1.74(0.21)       
Abnormal 
#3  52  57  562.4  120  703(153)  1.25(0.27)  775(53)  1.38(0.09) 
#4  40  68  569.8  108  901(150)  1.58(0.26)  n/a  n/a 
#6  32  83  584.6  145  880(75)  1.51(0.13)  883(102)  1.51(0.17) 
#9  79  90  636.4  77  751(153)  1.18(0.24)  1098(140)  1.73(0.22) 
#10 right  59  76  495.8  101      684(140)  1.38(0.28) 
Malignant  #7  68  78  514.3  85  1838(682)  3.57(1.33)  1095(244)  2.13(0.48) 
#8  61  70  543.9  91  n/a  n/a  14495(2127)  26.65(3.91) 
aTime difference between injection and measurement; 
bstd: standard deviation; 
cUnit: counts/MBq per 3 minutes. 
normal and abnormal ovaries was 0.72 to1.74 counts/MBq, and the range was 2.13 to 26.65 
for  malignant ovaries. In general, the count rates from left and right ovaries of the  same 
patient were similar except patients #7, #9 and #10. For patient #7, we obtained lower count 
rate from the right ovary which had multiple surface tumor nodules compared with the left 
ovary  which  had  extensive  surface  tumor  nodules  and  masses  invading  into  the  ovarian 
cortex.  For patient  #10,  the left  ovary  had  adhesions  due  to  lengthened  resection  process 
during surgery, resulting in an early acute inflammatory response with active hyperemia and 
margination of neutrophils. This may have caused the higher count rate compared with that of 
the right due to the increased local blood flow. For patient #9, the right side has higher count 
rate than that of the left which corresponds to an area of dense calcification in dense fibrous 
stroma. It is not clear whether this finding can be attributed to the fibrosis or the calcification. 
No  associated  necrosis  or  inflammation  was  seen  in  the  histologic  sections.  The 
histopathology and OCT features of 18 ovaries from three groups are given in Table 2. In 
general, the  normal ovarian  stroma appears homogeneous, relatively hyperintense in OCT 
images. Cysts and follicles appear as signal void circumferential regions of variable size with 
well-defined  boundaries.  Corpus  albicans,  focal  lymphocytes  and  calcifications  appear  as 
signal void or poor regions with variable size and shape. Carcinomas appear as either surface 
bumps with significant light shadowing or hyperintense bands embedded in poor images. One 
benign calcified, ossified dermoid tumor appears heterogeneous in OCT images. Because of 
the  small  sample  size  reported  in  this  pilot  study,  the  sensitivity  and  specificity  of  these 
features in predicting normal and malignant ovarian tissues are not available. 
Table 2. Corresponding histopothology and OCT features of 18 ovaries obtained from 10 
patients 
Category  Histopathology  OCT 
Normal 
(1, 2, 5, 
10(left)) 
Homogeneous cortical stroma  Homogenous, hyperintense 
Corpus albicans near surface  Signal void region with variable shape and size 
Inclusion cysts  Signal poor region with circumferential shape 
Abnormal 
(3, 4, 6, 9, 
10(right)) 
Large simple cysts, large follicles  Well defined boundary 
Small simple cyst  Signal void region with circumferential shape 
Cellular ovarian cortical stroma  Well-defined two hyperintense layers 
Prominent calcification  Signal void region with variable shapes 
Focal lymphocytes  Signal void region with variable shapes 
Vasculatures, congested vessels  Signal poor bands, circles or variable shapes 
Calcified, ossified dermoid tumor  Heterogeneity, signal poor regions 
with variable shape and size 
Malignant 
(7, 8) 
Surface tumor nodules 
(serous carcinoma) 
Circumferential or semi-
circumferential bumps deposited on the surface 
Small amount of collagenous stroma  Hyperintense region with irregular pattern 
Corpora albicans  Signal void region with undefined bottom 
All carcinoma with bands of collagen  Hyperintense bands embedded in poor image 
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postmenopausal woman # 5 is shown in Fig. 2. It shows the positron distribution map (a), one 
representative B-scan OCT image selected from a sequence of co-registered OCT images (b), 
and the corresponding 40× H&E histology slide (c). As described in Section 2.3, photons 
received from each scintillating fiber were scattered over the 2.5 × 2.5 mm
2 PSPMT detection 
surface and the outputs of the Anger logic were distributed within the circle that corresponded 
to each scintillating fiber as shown in Fig. 2(a). The positron count rate was 0.95 counts/MBq 
for this location. The homogeneous OCT image had some bright spots near the surface. The 
corresponding histology showed dense cortical stroma in the OCT imaging depth range. 
 
Fig.  2.  One  set  of images  obtained  from  the  left  ovary  of  normal patient #5.  (a)  Positron 
distribution map. (b) One representative OCT image obtained from a sequence of co-registered 
OCT images. (c) Corresponding 40× H&E histology. The OCT image size is 2 mm (depth) × 5 
mm (lateral) (height × width); the histology size is 2 mm × 2.6 mm (height × width); the white 
scale bar is 0.5 mm. 
An example of an abnormal ovary obtained from a 59-year-old postmenopausal woman 
#10 is shown in Fig. 3. The figure shows the positron distribution map (a), one representative 
B-scan  OCT  image  selected  from  a  sequence  of  co-registered  OCT  images  (b),  and  the 
corresponding 40 × H&E slide (c) obtained from the right ovary. The positron count rate was 
1.47 counts/MBq in this area. The OCT image showed heterogeneous hyperintense bands 
corresponding  to  collagen  bundles  as  marked  by  pink  arrows  and  hypointense  areas 
corresponding to blood vessels as marked by red oval arrows. These collagen bundles and 
blood vessels surrounded a dermoid tumor as marked by the yellow diamond arrow and were 
deeper than OCT could detect. 
One set of images obtained from the left ovary of the abnormal patient #9 is shown in Fig. 
4. The yellow ellipse in (a) is the map of the entire left ovary and the three solid squares 
represent three probe positions with the positron count rates shown inside the squares. 1.8-fold 
higher count rate was measured in the middle which indicated an abnormal local uptake of 
18F-FDG. Figure 4 (b) is the positron distribution map obtained at this location and an OCT 
image  (c)  revealed  a  well-defined  void  area.  The  corresponding  40×  H&E  shown  in  (d) 
revealed  lymphocytes  known  to  have  higher  metabolic  activities  than  normal  tissue  and 
yielded a false positive in positron detection. However, the well-defined hypointense void 
area in OCT can help rule out malignancy. This example highlights the synergistic role of the 
hybrid  probe  in  screening  for  both  abnormal  metabolic  activity  of  early  cancers  and 
simultaneous high-resolution imaging of morphological details of the abnormality or early 
cancer. 
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Fig. 3. One set of images obtained from the right ovary (abnormal) of patient #10. (a) Positron 
distribution map. (b) One representative OCT image obtained from a sequence of co-registered 
OCT images. (c) Corresponding 40× H&E histology. Pink arrow, collagen; red oval arrow, 
congested  vessels;  yellow  diamond  arrow,  dermoid  tumor.  The  OCT  image  size  is  2  mm 
(depth) × 5 mm (lateral) (height × width); the histology size is 2mm × 2.6 mm (height × width); 
the white scale bar is 0.5 mm. 
 
Fig. 4. One set of images obtained from the left ovary of abnormal patient #9. (a) Positron 
count  rates  from  different  locations  of  left  ovary.  (b)  Positron  distribution  map  from  the 
location with highest count rate. (c) One representative OCT image obtained from a sequence 
of co-registered OCT images. (d) Corresponding 40× H&E histology. Red circle, lymphocytes. 
The OCT image size is 2 mm (depth) × 5 mm (lateral) (height × width); the histology size is 
2mm × 2.6 mm (height × width); the white scale bar is 0.5 mm. 
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Fig. 5. Two sets of images obtained from the left ovary of patient #7 with malignant ovarian 
cancers. (a), (b) and (c) are from one side of the left ovary; (d), (e) and (f) are from the other 
side of the left ovary. (a) and (d): Positron distribution maps. (b) and (e) Representative OCT 
images obtained from a sequence of co-registered OCT images. (c) and (f) Corresponding 40× 
H&E histology. Pink arrow, collagen; purple stealth arrow, tumor nodule. The OCT image size 
is 2 mm (depth) × 5 mm (lateral) (height × width); the histology size is 2mm × 2.6 mm (height 
× width); the white scale bar is 0.5 mm. 
An example of ovarian carcinoma obtained from a 68-year-old postmenopausal woman 
(patient #7) is shown in Fig. 5. Two sets of images were given with the first set (a-c) obtained 
from one side of the ovary and second set (d-f) from the opposite side of the ovary. The 
positron count rate (a) from the first set of data was 1.95 counts/MBq and 1.6 times higher 
than that obtained from normal ovaries. OCT image (b) showed high content collagen with 
irregular patterns which matched the collagen bundles marked in corresponding H&E slide 
(c).  The  positron  count  rate  (d)  obtained  from  the  opposite  side  of  the  ovary  was  5.04 
counts/MBq and was 4.1 times higher than normal ovaries. The representative OCT image (e) 
clearly provided the nodule shape with significant light shadowing beneath the tumor nodule. 
The light shadowing was caused by the light absorption of the tumor. The corresponding H&E 
(f) showed the tumor nodule deposited on the ovary surface. Figure 6 shows one set of data 
obtained from the right ovary of the same patient #7. The positron count rate (a) from this 
location was 2.90 counts/MBq and was 2.4 times higher than that of the normal ovaries. The 
signal void region (red circle) shown in OCT image (b) corresponds to corpus albicans shown 
in the H&E histology (c) and the purple stealth arrows mark the cancer cells deposited on the 
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amount  of  local  tumor  mass  and  could  be  potentially  used  as  the  screening  tool  during 
minimally invasive surgery for guiding the OCT to look into morphological changes in great 
details. 
 
Fig. 6. One set of images obtained from the right ovary of patient #7 with ovarian cancers. (a) 
Positron distribution map. (b) One representative OCT image obtained from a sequence of co-
registered OCT images. (c) Corresponding 40× H&E histology. Red circle, corpus albicans; 
purple stealth arrow, tumor. The OCT image size is 2 mm (depth) × 5 mm (lateral) (height × 
width); the histology size is 2mm × 2.6 mm (height × width); the white scale bar is 0.5 mm. 
An example of advanced ovarian carcinoma obtained from a 61-year old postmenopausal 
woman is given in Fig. 7. This patient had ovarian cancer on both sides; however, only the 
right  ovary  was  studied.  The  left  ovary  was  not  optimal  for  positron  detection  due  to 
prolonged surgical time required for removal. The positron count rates (a) and (d) from the 
right ovary were 17~28 times higher than normal ovaries. OCT images revealed irregular 
patterns of hyperintense layers (b) and hyperintense regions (e) as marked in representative 
OCT images which represent a change in shape and directionality of the collagen fibers which 
were seen in the early cancers but are much more dramatic here. The H&E showed thick 
collagen bands embedded in the tumor cells (c) and (f) which matched the OCT hyperintense 
layers (b) and regions (e). This example demonstrates the great clinical potential of the dual-
modality device for extremely sensitive detection of ovarian cancers. 
4. Discussion 
This study, to the best of our knowledge, reports the first ex vivo findings of positron count 
rates between malignant and abnormal/normal ovaries using 
18F-FDG as a tracer. The ratio of 
7.5/8.8-fold higher was found between malignant and abnormal/normal ovaries. Other studies 
of thyroid cancer [6], head and neck cancer [31], colon and skin cancers [6], and metastatic 
melanoma [32], obtained from small patient pool of 5-26 using beta probes have reported 
various cancer to normal tissue ratios of 1.2-17.2. 
In this study, the positron counting period was 3 minutes which could be long for surgeons 
to operate the device during laparoscopic surgical procedure. It is important to decrease the 
time needed for a quick diagnosis. Positron detectors with improved optical coupling between 
the scintillating fibers and the optical fibers and a detection circuitry with improved SNR have 
been developed during this one year clinical study period, which will improve the potential of 
this technology. The optimized detection circuitry and positron detector with better optical 
coupling and coating at the scintillator tip can effectively reduce the data acquisition time to 
30 seconds without affecting detection sensitivity. However, in order to keep consistency with  
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Fig. 7. Two sets of images obtained from the right ovary of patient #8 with ovarian cancers. (a), 
(b) and (c) are from one location; (d), (e) and (f) are from another location. (a) and (d) Positron 
distribution maps. (b) and (e) Representative OCT images obtained from a sequence of co-
registered OCT images. (c) and (f) Corresponding 40× H&E histology. Pink arrow, collagen 
bundle. The OCT image size is 2 mm (depth) × 5 mm (lateral) (height × width); the histology 
size is 2mm × 2.6 mm (height × width); the white scale bar is 0.5 mm. 
the data acquisition for all patients of different pathologies, we have used the reported system 
for all patients. In addition, a reduced rotational rate of 1 frame per 16 seconds was utilized in 
OCT system for the reported ex vivo studies. 10 frames per second which is adequate for in 
vivo study can be readily achieved by removing divider circuitry, improving data acquisition 
system  and  optimizing  image  processing  code.  Beyond  this  data  acquisition  speed,  the 
rotation  mechanics  which could generate  noise and OCT probe wobbling  will need to be 
considered and an improved design will need to be implemented. 
Our OCT imaging quality of ovarian tissue  was comparable to that obtained by other 
research  groups  [24–27].  However,  because  of  the  large  rotational  scanning  angle  of  the 
miniature ball lens catheter, the OCT imaging quality was poorer in general than the linear 
scanning  images.  Efforts  are  currently  underway  to  optimize  the  OCT  probe  design  and 
upgrade the OCT system to enable faster data acquisition and processing which will allow a 
larger number of averaging to improve OCT imaging quality. 
In this study we have used the total counts from all positron detectors on the hybrid probe 
as  a  measure  to  quantify  the 
18F-FDG  uptake  of  each  ovary.  In  principle,  the  weighted 
centroid algorithm on positron counts measured from all individual detectors can be used to 
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18F-FDG uptake [28]. However, because of the 
different  coupling  efficiency  between  the  scintillators  and  optical  fibers,  the  sensitivity 
variation  among  the  reported  positron  detectors  was  more  than  3:1  and  this  impeded  the 
application of centroid algorithm. With the help of micro-fabrication techniques we could 
make repeatable and precise positron probes having uniform sensitivity. The gain variation of 
PSPMT  channels  can  be  compensated  by  calibration.  In  future  studies  we  will  apply  the 
centroid algorithm using the improved detectors to help identify a small localized lesion with 
a high 
18F-FDG uptake. 
In our ex vivo study, the ambient gamma background collected by the two beta-shielded 
detectors  was  in  the  noise  level.  However,  this  gamma  background  level  could  be  much 
higher in in vivo imaging condition where the surrounding tissue would have significant 
18F-
FDG uptake and produce gamma photons. We anticipate that the gamma subtraction will be 
needed in future in vivo study and the effectiveness of the subtraction will be tested. 
Two major system design modifications are needed for fitting the intraoperative hybrid 
probe to a standard laparoscope accessory port of 5-12.5 mm diameter for in vivo evaluation 
of the ovary. The longitudinal distance of the current hybrid probe used in the reported study 
was more than 15 mm and the total width was more than 5mm. This relatively large size of 
the probe is the result of the optical fibers exiting the probe in the orthogonal arrangement as 
shown  in  Fig.  1(f),  which  makes  it  difficult  to  fit  the  entire  probe  within  a  5-12.5  mm 
laparoscope accessory port. We are currently  working on new designs that will allow the 
probe fit into a 5-12.5 mm laparoscope port for future in vivo evaluation during minimally 
invasive surgery. 
Summary 
In  this  report,  the  potential  role  of  a  prototype  intraoperative  probe  combining  positron 
detection and OCT imaging for ovarian cancer detection and characterization was evaluated 
using 18 ex vivo ovaries of various pathologic conditions. Positron count rates of 7.5/8.8-fold 
higher were found between malignant ovaries and abnormal/normal ovaries. OCT imaging of 
malignant and abnormal ovaries revealed many detailed morphologic features that could be 
potentially valuable for evaluating local regions with high metabolic activities and detecting 
early malignant changes of the ovary. 
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